Compounding Peptide Pricing Guides
Current prices from compounding pharmacies, telehealth platforms, and research vendors for popular therapeutic and research peptides.
Ipamorelin / CJC-1295 Pricing: April 2026
Ipamorelin/CJC-1295 combo runs $200–$600/mo through clinics, $80–$150/mo from research vendors. Regulatory status uncertain pending July 2026 FDA panel.
View prices → (Updated )KLOW Blend (KPV + GHK-Cu + BPC-157 + TB-500) Pricing: September 2026
KLOW 80 mg research vials now run $90-$170 (the $41 floor is gone); Chicago clinic programs $400-$1,040. PCAC backed 3 of the 4 peptides; GHK-Cu waits for 2027.
View prices →PT-141 (Bremelanotide) Pricing: April 2026
PT-141 is FDA-approved as Vyleesi ($0 with copay card, $99/box uninsured) and sold compounded from $180/mo as injection, nasal spray, or troches.
View prices →Sermorelin Pricing: April 2026
Sermorelin ranges from $79/mo (telehealth promo) to $500/mo (boutique clinics). Best value is telehealth at $99–$199/mo all-inclusive.
View prices → (Updated )TB-500 Pricing: September 2026
TB-500 runs $35-$70 per research vial and $120-$450/mo through clinics; BPC-157/TB-500 telehealth starts at $199/mo. PCAC voted 8-6 for it in July.
View prices →Tesamorelin (Egrifta) Pricing: April 2026
Tesamorelin's 100x price gap: Egrifta WR $3,000–$10,000+/mo retail (often $0 with THERA copay), compounded telehealth from $199/mo, research vials from $36.
View prices →Wolverine Stack (BPC-157 + TB-500) Pricing: April 2026
The Wolverine Stack (BPC-157 + TB-500) runs $199–$350/mo through telehealth, $200–$600/mo at clinics. Research blend vials start at ~$60. Nasal sprays from $62.
View prices →